Future State of Smallpox Medical Countermeasures (2024) / Chapter Skim
Currently Skimming:
Appendix A: Study Methods and Public Meeting Agendas
Appendix A: Study Methods and Public Meeting Agendas
Pages 147-158
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 147... ...
Targeted literature reviews were conducted as novel issues arose throughout the committee's deliberations. All written information provided to the committee from external sources is available by request through the National Academies' Public Access Records Office.
|
From page 148... ...
government and international partners on key activities and perspectives relevant to the charge. • Hear from subject matter experts on different issues related to variola and poxvirus research and medical countermeasure development.
|
From page 149... ...
Variola Virus Research -- Overview of Main Activities and Use of Live Virus CHRISTY HUTSON Chief, Poxvirus and Rabies Branch Division of High Consequence Pathogens and Pathology U.S. Centers for Disease Control and Prevention (CDC)
|
From page 150... ...
Welcoming Remarks LARRY GOSTIN, Committee Chair Distinguished University Professor and O'Neill Chair in Global Health Law O'Neill Institute for National and Global Health Law Georgetown University SESSION II U.S. Government Updates Objectives: Hear briefings from federal stakeholders on current activities for smallpox medical countermeasures.
|
From page 151... ...
Response Panel STEVE ADAMS Director, Strategic National Stockpile ASPR DANIEL WOLFE Branch Chief, CBRN Vaccines BARDA KAREN MARTINS Branch Chief, CBRN Antivirals and Antitoxins BARDA MARGARET SLOANE Office of Strategy, Policy, and Requirements ASPR SESSION III Smallpox Medical Countermeasures Landscape Objectives: (1) Examine current state of MCMs for the prevention and treatment of smallpox, and (2)
|
From page 152... ...
Therapeutics Research and Development INGER DAMON, Moderator, Committee Member CYRUS JAVAN Medical Officer Division of AIDS NIAID DENNIS HRUBY Chief Scientific Officer SIGA SESSION IV Scenario Planning and MCM Stockpiling Strategies Objectives: (1) Explore how recent COVID-19 and mpox public health emergencies have altered assumptions about the U.S.
|
From page 153... ...
3:45 p.m. Scenario Planning and MCM Stockpiling Strategies HENRY WILLIS, Moderator, Committee Member NATHANIEL HUPERT Associate Professor of Population Health Sciences Cornell University Weill Medical College CRYSTAL WATSON Senior Scholar and Associate Professor Johns Hopkins Center for Health Security KEVIN YESKEY Senior Advisor for Emergency Public Health MDB, Inc.
|
From page 154... ...
SESSION VI Day 2 Opening Session 12:30 p.m. Welcoming Remarks LARRY GOSTIN, Committee Chair Distinguished University Professor and O'Neill Chair in Global Health Law O'Neill Institute for National and Global Health Law Georgetown University SESSION VII Synthetic Biology Opportunities and Risks Objectives: (1)
|
From page 155... ...
12:45 p.m. Lessons Learned and Future Considerations GEORGES BENJAMIN, Moderator, Committee Member MATTHEW HEPBURN Chief Medical Officer JPEO-CBRND EWA KING Chief Program Officer Association of Public Health Laboratories (APHL)
|
From page 156... ...
2:30 p.m. Welcoming Remarks LARRY GOSTIN, Committee Chair Distinguished University Professor and O'Neill Chair in Global Health Law O'Neill Institute for National and Global Health Law Georgetown University 2:35 p.m.
|
From page 157... ...
3:55 p.m. Wrap-Up and Closing Remarks LARRY GOSTIN, Committee Chair Distinguished University Professor and O'Neill Chair in Global Health Law O'Neill Institute for National and Global Health Law Georgetown University 4:00 p.m.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.